WHO ICTRP trial
JPRN-jRCT2080225125
JPRN-jRCT2080225125 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2080225125 |
|---|---|
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Japan;Asia except Japan;North America;null |
| Interventions | investigational material(s) Generic name etc : INN of investigational material : Mirikizumab Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : control… |
| Registration date | Mar 16, 2020 |
| Target size | 30 |
| Secondary IDs | NCT04004611;JapicCTI-205220 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: